Zentek (ZTEK) said Wednesday its Triera unit has won a $1.1 million research and development contract through the Canadian government's Innovative Solutions Canada program.
The company has been tasked to create an H5N1 bird flu vaccine within six months, with the testing phase due to be carried out at McMaster University's Miller Laboratory, the company said.
Testing partners for the project include Health Emergency Readiness Canada and Canada's Department of National Defence's Defence Research and Development Canada, it added.
The company's shares were down nearly 7.4% in recent Wednesday trading.
Price: 0.78, Change: -0.06, Percent Change: -7.38
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。